83
Participants
Start Date
September 1, 2007
Primary Completion Date
February 28, 2011
Study Completion Date
February 28, 2011
AMES device (test)
Eighteen treatment sessions for each qualifying subject limb using the AMES device. Each treatment session being 30 minutes long. Sessions to be scheduled preferable 2 to 3 times per week, with the 18 sessions to be completed within the 6 month anniversary date of the subject's stroke.
AMES device (sham)
Eighteen treatment sessions for each qualifying subject limb using the AMES device (sham) in which the limb is moved, but no active assistance is provided by the subject and the vibration is delivered at a very low frequency to the shortening (i.e., rather than lengthening) muscle. Each treatment session to provide thirty minutes of the placebo form of AMES therapy.
AMES device (crossover)
Eighteen treatment sessions for each qualifying subject limb using the AMES device. Each treatment session being 30 minutes long. Sessions to be scheduled preferable 2 to 3 times per week, with the 18 sessions to be completed as soon as possible after the completion of Arm C-1 Sham Comparator.
Emory University Dept of Rehabilitation Medicine/School of Medicine, Atlanta
Rehabilitation Institute of Chicago, Chicago
Eisenhower Medical Center, Rancho Mirage
UCSF School of Medicine- Physical Therapy and Rehabilitation, San Francisco
NW Medical Rehabilitation, Spokane
Lead Sponsor
Collaborators (1)
Northwest Medical Rehabilitation, Spokane, WA
UNKNOWN
Emory University
OTHER
University of California, San Francisco
OTHER
Shirley Ryan AbilityLab
OTHER
Eisenhower Medical Center
OTHER
Legacy Health System
OTHER
AMES Technology
INDUSTRY